Literature DB >> 32253545

Antidepressant Use in a 3- to 12-Year Follow-up of Anxious Youth: Results from the CAMELS Trial.

Elana R Kagan1, Hannah E Frank2, Lesley A Norris2, Sophie A Palitz2, Erika A Chiappini3, Mark J Knepley2, Margaret E Crane2, Katherine E Phillips2, Golda S Ginsburg4, Courtney Keeton3, Anne Marie Albano5, John Piacentini6, Tara Peris6, Scott Compton7, Dara Sakolsky8, Boris Birmaher8, Philip C Kendall2.   

Abstract

The current study explored whether patient characteristics predicted patterns of antidepressant use (i.e., never used, single episode of use, or two or more episodes) in a naturalistic follow-up. Participants in the child/adolescent multimodal (CAMS) extended long-term study. (n = 318) indicated medication use over the course of eight follow-up visits, 3-12 years after receiving treatment in CAMS. 40.6% of participants reported never using an antidepressant during follow-up, 41.4% reported a single episode of antidepressant use, and 18.0% reported multiple episodes of antidepressant use. Greater baseline anxiety severity marginally predicted a single episode of antidepressant use; baseline depression severity predicted multiple episodes of use. Reasons for discontinuing antidepressants included perceived ineffectiveness (31.8%), side effects (25.5%), and improvement in symptoms (18.5%). Exploratory analyses examined predictors of medication use. Findings suggest that antidepressant use is common among anxious youth, as is discontinuation of antidepressant use. Clinical implications and future directions are discussed.

Entities:  

Keywords:  Antidepressant; Anxiety; Longitudinal; Treatment

Mesh:

Substances:

Year:  2021        PMID: 32253545      PMCID: PMC7541463          DOI: 10.1007/s10578-020-00983-w

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN: 0009-398X


  39 in total

1.  Fluoxetine for the treatment of childhood anxiety disorders: open-label, long-term extension to a controlled trial.

Authors:  Duncan B Clark; Boris Birmaher; David Axelson; Kelly Monk; Catherine Kalas; Mary Ehmann; Jeffrey Bridge; D Scott Wood; Bengt Muthen; David Brent
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2005-12       Impact factor: 8.829

2.  What five decades of research tells us about the effects of youth psychological therapy: A multilevel meta-analysis and implications for science and practice.

Authors:  John R Weisz; Sofie Kuppens; Mei Yi Ng; Dikla Eckshtain; Ana M Ugueto; Rachel Vaughn-Coaxum; Amanda Jensen-Doss; Kristin M Hawley; Lauren S Krumholz Marchette; Brian C Chu; V Robin Weersing; Samantha R Fordwood
Journal:  Am Psychol       Date:  2017 Feb-Mar

3.  Life course outcomes of young people with anxiety disorders in adolescence.

Authors:  L J Woodward; D M Fergusson
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-09       Impact factor: 8.829

4.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 5.  Treating children and adolescents with selective serotonin reuptake inhibitors: how long is appropriate?

Authors:  Daniel S Pine
Journal:  J Child Adolesc Psychopharmacol       Date:  2002       Impact factor: 2.576

6.  Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A).

Authors:  Kathleen Ries Merikangas; Jian-Ping He; Marcy Burstein; Sonja A Swanson; Shelli Avenevoli; Lihong Cui; Corina Benjet; Katholiki Georgiades; Joel Swendsen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-07-31       Impact factor: 8.829

Review 7.  Comorbidity of anxiety and depression in children and adolescents: 20 years after.

Authors:  Colleen M Cummings; Nicole E Caporino; Philip C Kendall
Journal:  Psychol Bull       Date:  2013-11-11       Impact factor: 17.737

8.  Properties of the mood and feelings questionnaire in adolescent psychiatric outpatients: a research note.

Authors:  A Wood; L Kroll; A Moore; R Harrington
Journal:  J Child Psychol Psychiatry       Date:  1995-02       Impact factor: 8.982

Review 9.  Pediatric generalized anxiety disorder: epidemiology, diagnosis, and management.

Authors:  Courtney Pierce Keeton; Amie C Kolos; John T Walkup
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

10.  Remission status after long-term sertraline treatment of pediatric obsessive-compulsive disorder.

Authors:  Karen Dineen Wagner; Edwin H Cook; Henry Chung; Michael Messig
Journal:  J Child Adolesc Psychopharmacol       Date:  2003       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.